The Role of Chimeric Antigen Receptor T-Cell Therapy in the Era of Bispecific Antibodies

被引：2
|
作者：
Nath, Karthik [1 ]
Mailankody, Sham [1 ,2 ,3 ]
Usmani, Saad Z. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Cellular Therapy Serv, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA
[3] Weill Cornell Med Coll, Dept Med, New York, NY USA
[4] Mem Sloan Kettering Cance, Adult Bone Marrow Transplant Serv, New York, NY USA
[5] 30 East 74th St,Room 20-228, New York, NY 10021 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
CAR T-cell therapy; Bispecific antibodies; Immunotherapeutic agents; Multiple myeloma; MULTIPLE-MYELOMA; MATURATION ANTIGEN; PLUS LENALIDOMIDE; PHASE-3; RISK; BCMA;
D O I：
10.1016/j.hoc.2023.05.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1201 / 1214
页数：14
相关论文
共 50 条
  • [41] Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors
    Wala, Jeremiah A.
    Hanna, Glenn J.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1149 - 1168
  • [42] Ophthalmic Implications of Chimeric Antigen Receptor T-Cell Therapy
    Chodnicki, Kevin D.
    Prasad, Sashank
    SEMINARS IN OPHTHALMOLOGY, 2021, 36 (04) : 329 - 334
  • [43] Cardiovascular Toxicities with Chimeric Antigen Receptor T-cell Therapy
    Gill, Jashan
    CURRENT CARDIOLOGY REVIEWS, 2023, 19 (01) : 54 - 54
  • [44] Utilization of Chimeric Antigen Receptor T-cell Therapy in Adults
    Dudley, Channing Vail
    Baer, Brittney
    Simons, Rhea Micci
    SEMINARS IN ONCOLOGY NURSING, 2019, 35 (05)
  • [45] OPTIMIZATION OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR MEDULLOBLASTOMA
    Nellan, Anandani
    Rota, Christopher
    Warren, Katherine
    Lee, Daniel
    NEURO-ONCOLOGY, 2016, 18 : 106 - 106
  • [46] Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist
    Maus, Marcela V.
    Levine, Bruce L.
    ONCOLOGIST, 2016, 21 (05): : 608 - 617
  • [47] Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma
    Atrash, Shebli
    Ali, Syed Abbas
    Usmani, Saad Z.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01): : 21 - 34
  • [48] Chimeric antigen receptor T-cell therapy for multiple myeloma
    Naoki Hosen
    International Journal of Hematology, 2020, 111 : 530 - 534
  • [49] Chimeric antigen receptor T-cell therapy remains effective after exposure to bispecific antibodies. Comment to "Sequencing of cellular therapy and bispecific antibodies for the management of diffuse large B-cell lymphoma"
    Crochet, Gilles
    Houot, Roch
    HAEMATOLOGICA, 2025, 110 (03) : 808 - 808
  • [50] Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia
    Oh, Bernice L. Z.
    Vinanica, Natasha
    Wong, Desmond M. H.
    Campana, Dario
    HAEMATOLOGICA, 2024, 109 (06) : 1677 - 1688
12345